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INTRODUCTION:  Bladder  exstrophy  is a very  rare  congenital  anomaly  and  is associated  with  an increased
incidence  of  bladder  cancer.  Most  patients  undergo  reconstructive  operations  during  childhood.
PRESENTATION  OF  CASE:  A 53  year-old  woman  was diagnosed  with  enteric  type  mucinous  adenocarci-
noma  of  the  unreconstructed  exstrophic  bladder.  Preoperative  examination  revealed  no  primary  site
in the  gastrointestinal  system.  The  patient  underwent  an  anterior  pelvic  exenteration  with  bilateral
ureterostomy  and repairing  of  the  anterior  abdominal  wall  defect  with  a  mesh.
DISCUSSION:  Carcinoma  of  the  exstrophic  bladder  is  a very  rare  entity.  An  overall  number  of  118 cases  of
cancer  in unreconstructed  bladder  have  been  reported  in  the  literature  since  1895  with adenocarcinomasarcinoma
nreconstructed bladder
ase reports
consisting  of  90–91%  and  squamous  cell carcinomas  8.5%.  Mechanical  irritation  on  the  bladder  mucosa,
embryologic  origin  and  urine  carcinogens  are  some  o  the theories  of  cancerous  metaplasia.
CONCLUSION:  This  is the  ﬁrst case of bladder  exstrophy  cancer  reported  that  was  submitted  to  anterior
pelvic  exenteration.  We  propose  this  surgical  procedure  as an  appropriate  alternative  in  postmenopausal
women  and cancer  of  the  unreconstructed  bladder  exstrophy.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Exstrophy of the bladder is a very rare congenital anomaly asso-
iated with increased incidence of bladder cancer. It consists of a
ery troublesome defect for the patients who suffer from it. Many
ew surgical techniques have been developed lately and repairing
f the exstrophy during childhood is the rule in the vast major-
ty of cases. The quality of life of patients with exstrophy has been
arkedly improved permitting them to live a normal life. However
ue to several reasons, some patients remain with unreconstructed
xstrophic bladder until adulthood. Here we present a rare case of
 53 year-old woman with a mucinous adenocarcinoma occurring
n the unreconstructed exstrophic bladder.
. Case report
A 53 year-old woman with bladder exstrophy was admitted to
ur department because of vaginal bleeding. Clinical evaluation
evealed the presence of a round, polypoid, irregular, friable, ulcer-
ted mass in the hypogastric region, which affected the clitoris
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and the labia majora. The lesion was  bleeding during palpation.
Umbilicus was  absent. Bilateral inguinal lymph nodes were not pal-
pable. Routine laboratory investigations were within normal limits.
Biopsies of the bladder mass revealed an intestinal type adeno-
carcinoma. According to immunohistochemistry control: CK 20(+),
CDX2(+), CEA(−), CK 7(−),  CK 34(−), BE 12(−), the most possible
cause is considered the urachal remnants, while the endoscopic
examination of upper and lower gastrointestinal tract was negative.
Examination under anaesthesia was  performed, where a polypoid
mass of the anterior abdominal wall was  recognized behind the
pubic symphysis (Fig. 1). Its diameter was around 10 cm.  Vagina
and the external cervical opening were recognized, but not as well
the external urethral meatus. A deﬁcit of anterior wall muscles was
tested. The left ureteral opening was seen, with clear urine output,
but the right ureteral opening could not be identiﬁed. A biopsy of
the mass was taken. Contrast-enhanced axial CT image through the
abdomen and pelvis demonstrated a midline, infraumbilical soft-
tissue mass of the anterior abdominal wall extending to the vulva
along with anterior displacement of the anus and wide separation
of the pubic symphysis. Pelvicalyceal systems and ureters were
dilated. The ureters in their termination had an abnormal anterior
course. There was no identiﬁable shape of urinary bladder. Absence
of bladder ﬁlling was  also noticed at the delayed scan (Fig. 2). Com-
puted tomography of the thorax and mammography were normal.
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Bladder exstrophy complicated by carcinoma. A round, polypoid, friable mass
of 10 cm diameter, with concomitant rotation of the innominate bones and diastasis
of  pubic symphysis.
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rig. 2. Polypoid, enhancing, soft-tissue mass of the hypogastrium. External rotation
f  the innominate bones with concomitant diastasis of pubic symphysis and anterior
osition of the rectum.
nterior pelvic exenteration was performed with en bloc removal
f the exstrophic bladder, the uterus, the adnexa, the rudimentary
atch of the vagina and the lower ureter thirds bilateral. A bilateral
xternal ureterostomy also was occurred. Abdominal wall closure
as a difﬁcult procedure and the ifraumbilical deﬁcit was closed by
 mesh. In the bladder a low-grade (Gr1) mucous adenocarcinoma
as seen, probably originating from the exstrophy of the urinary
ladder. Our patient had an excellent post-operative outcome with-
ut inﬂammation of trauma, fever elevation or any renal disorder.
he patient was released on the 12th postoperative day. The patient
as not given any adjuvant therapy and is doing well at six months
f follow up.
. Discussion
Exstrophy of the urinary bladder is an uncommon congenital
eformity with an incidence of about 2.07–2.15 cases in 100,000
ive births [1]. The male to female ratio of bladder exstrophy derived
rom multiple series is 2.3:1. It is not familial, although the risk
f recurrence in a family with Bladder Exstrophy and Epispadias
omplex is about 1 in 70 live births. Recent published evidence
uggests that the risk of bladder exstrophy in children born as a
esult of assisted fertility techniques is eight times greater than inPEN  ACCESS
 Surgery Case Reports 25 (2016) 13–15
children conceived naturally [2]. The malformation is deﬁned as
an incomplete fusion of the mesoderm, which forms the tubercle
genitalia, anterior wall of the bladder and inferior portion of the
anterior abdominal wall, due to the failure of mesenchymal cells
to migrate between the ectoderm and endoderm of the abdomi-
nal wall. Diastasis of muscle recti and symphysis, eversion of the
posterior bladder wall including the ureteral oriﬁces in the ante-
rior abdominal wall, separated scrotum/labia majora and divided
penis/clitoris are some characteristics of bladder exstrophy.
Since the early 70 s surgical intervention has been recom-
mended in childhood in order to gain continence of urine, maintain
patient’s renal function, reconstruct the external genitalia and
avoid the occurrence of carcinoma [3]. Because most of the patients
with bladder exstrophy undergo reconstruction at a younger age,
treatment of bladder exstrophy in adult patients is occasionally
reported in the literature, and delayed presentation may  be due
to ignorance, lack of proper medical facilities or social embar-
rassment. The latter sometimes force patients to come up with
ingenious devices in order to solve their problem and not to seek
medical advice [4]. Nevertheless, carcinoma developing in bladder
exstrophy still occurs and patients at the adulthood are at risk of
developing malignant tumors, even after functional closing.
Adenocarcinoma of the urinary bladder is a rare malignant
neoplasm and accounts for 1.6% of bladder cancers. However, it
accounts for more than 90% of carcinomas of the exstrophic bladder.
On 1895 we  have the ﬁrst of a case of carcinoma of the unrecon-
structed bladder exstrophy [5]. Nielsen and Nielsen [6], reviewed
81 cases since 1983 and until this present report a total of 118
cases including ours, have been reported. Squamous cell carcinoma
stands for 10 out of 118 cases (8.5%) and adenocarcinomas are the
majority of the remaining, which makes an incidence of 90–91%
among patients with bladder exstrophy.
The malignant potential of the exstrophied bladder mucosa is
well known. The incidence of carcinoma in exstrophy of the blad-
der varies among 4% and 7.5% in different reports. That makes
the risk of malignancy in exstrophy of the bladder much higher
than in the average population, where the risk of bladder carci-
noma accounts for 20 in 100,0000. In a large cohort of 103 patients
born with exstrophy of the bladder the incidence of neoplasia after
a minimum of 35 years of follow-up was 4%, which is 694 times
greater incidence in the risk of bladder cancer than in the normal
population. Cystectomy does not prevent the malignancy occur-
rence and all cancers developed in men, a fact that according to the
authors may  possibly be due to male anatomy that does not permit
as extended cystectomy as in the female [7].
On the other hand there is a high risk of colorectal neoplasia as a
consequence of reconstructive surgery which permits the urinary
and fecal streams to mix  in a common reservoir (ureterosigmoidos-
tomy, vesicocolic anastomosis). Patients who  have been submitted
to this kind of operations were found to have a 1726-fold greater
incidence of adenocarcinoma of the colon. Annual colonoscopy of
patients deemed at high risk of colorectal neoplasia appears to be
an effective screen for colorectal carcinoma, by identifying a pre-
malignant stage [7].
The cause of the carcinogenesis in exstrophic bladder is
unknown yet, although there are different theories for the expla-
nation of the higher risk and the histology of the tumors. The
epithelium of the exstrophic bladder shows glandular metaplasia
in the middle of the bladder and squamous at the top of the trigone
merging into normal skin [8]. Squamous metaplasia was  a ﬁnding
in the pathology specimen of our case also. Corica et al. followed
up 29 children with bladder exstrophy and intestinal metaplasia of
the bladder and after a median range of 13 (3–23.9) years patients
had no evidence of bladder cancer. This led the authors to conclude
that intestinal metaplasia is not a risk factor for adenocarcinoma of
the exstrophic bladder [9].
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Mechanical irritation on the bladder mucosa has been hypoth-
sized to be the stimulus of the metaplastic process, leading later
o carcinogenesis. As early as 1921 Lower believed that the irri-
ation from the metal collector his patient invented caused the
arcinoma.13 This theory is further supported by the fact that
ost patients develop carcinoma in their forties or ﬁfties and
hronic inﬂammatory symptoms of the mucosa are visible histo-
ogically in bladder sections not invaded by the tumor. Exposure
f the exstrophic bladder to the environment and constant infec-
ion results in glandular metaplasia, possibly to produce protective
ucus and this may  be the origin of the malignant change.
Another hypothesis is the inﬂuence of carcinogenic substances
rom the urine on the mucosa [10]. There are multiple reports of
atients who had colon adenocarcinoma after ureterosigmoidos-
omy. Therefore development of colon cancer adenocarcinoma at
he ureterosigmoidostomy site is well established, and the risk is
00–550 times greater than general population and 7000 greater
mong than people <25 years old.
The last theory is the embryological origin of these tumors espe-
ially adenocarcinomas of the colonic type in bladder exstrophy
ike the one in our case. This is probably due to an originally rectal
pithelium misplaced during the division of the cloaca. However
evelopment of carcinomas mostly in the 5th of 6th decade is
gainst the usual behavior of tumors of embryological origin. In an
nteresting report Eastman et al., found that von Brunn’s nests are
specially prevalent in the exstrophic bladder, a birth defect that
redisposes the patient to formation of bladder cancer. They dis-
overed also that the exstrophic condition appears to have hijacked
he FGF-10 signal transduction system to serve as the principle
itogenic mechanism which underlies the proliferation and devel-
pment of von Brunn’s nests in the exstrophic bladder [11].
Anterior pelvic exenteration with bilateral ureterostomy is the
peration we chose to proceed with in our case. Pelvic exenteration
efers to an ultraradical surgical procedure consisting of an en bloc
esection of the female reproductive organs, lower urinary tract,
nd a portion of the rectosigmoid. In an anterior pelvic exenteration
he rectum is spared and is suitable for lesions conﬁned to the cervix
nd the anterior upper vagina. The goal is to remove the bladder, the
rethra and anterior vagina but save posterior vagina and rectum. It
ay  be offered to women with recurrent or advanced gynecological
ancer with extensive central pelvic disease that cannot be resected
ith a lesser procedure and in whom radiation is not an option
12]. This operation is usually undertaken by laparotomy by robotic
nterior exenteration is another option with favorable operative,
athologic and short term clinical outcome. Furthermore, the same
esults have been reported in robot assisted laparoscopic anterior
elvic exenteration for bladder cancer.
. Conclusion
To the best of our knowledge this is one of the few cases of cancer
n exstrophic bladder reported in the literature that was treated in
 gynecology department, and the ﬁrst case that an anterior pelvic
xenteration has been chosen as the proper surgical operation. The
esults were excellent. Postoperative condition of the patient was
emarkable with no early or late complications. For that reason we
dvocate anterior pelvic exenteration to be an alternative option
o radical cystectomy for the treatment of postmenopausal women
ith cancer of bladder exstrophy.
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